Skip to content

Author

Giulia Lorenzetti

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Improvement of pregnancy outcome following primary CMV infection after the introduction of valacyclovir in the clinical practice in Italy, updated data from a large real-life multicenter study.

BACKGROUND Congenital cytomegalovirus infection (cCMV) is a leading cause of neurodevelopmental impairment and congenital sensorineural hearing loss (SNHL). Since December 2020, valacyclovir (VCV) is reimbursed by the Italian National Health System to reduce maternal-fetal CMV transmission following primary CMV materna...

L. Zammarchi, Anna Beltrami, G. Liuzzi et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.